Depression and HIV: a scoping review in search of neuroimmune biomarkers
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
People with HIV are at increased risk for depression, though the neurobiological mechanisms underlying this are unclear. In the last decade, there has been a substantial rise in interest in the contribution of (neuro)inflammation to depression, coupled with rapid advancements in the resolution and sensitivity of biomarker assays such as Luminex, single molecular array and newly developed positron emission tomography radioligands. Numerous pre-clinical and clinical studies have recently leveraged these next-generation immunoassays to identify biomarkers that may be associated with HIV and depression (separately), though few studies have explored these biomarkers in co-occurring HIV and depression. Using a systematic search, we detected 33 publications involving a cumulative N = 10 590 participants which tested for associations between depressive symptoms and 55 biomarkers of inflammation and related processes in participants living with HIV. Formal meta-analyses were not possible as statistical reporting in the field was highly variable; future studies must fully report test statistics and effect size estimates. The majority of included studies were carried out in the United States, with samples that were primarily older and primarily men. Substantial further work is necessary to diversify the geographical, age, and sex distribution of samples in the field. This review finds that alterations in concentrations of certain biomarkers of neuroinflammation (interleukin-6, tumour necrosis factor-α, neopterin) may influence the association between HIV and depression. Equally, the chemokines monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) or the metabolic index kynurenine:tryptophan (Kyn:Trp), which have been the focus of several studies, do not appear to be associated with depressive symptoms amongst people living with HIV, as all (MCP-1) or most (IL-8 and Kyn:Trp) available studies of these biomarkers reported non-significant associations. We propose a biomarker-driven hypothesis of the neuroimmunometabolic mechanisms that may precipitate the increased risk of depression among people with HIV. Chronically activated microglia, which trigger key neuroinflammatory cascades shown to be upregulated in people with HIV, may be the central link connecting HIV infection in the central nervous system with depressive symptoms. Findings from this review may inform research design in future studies of HIV-associated depression and enable concerted efforts towards biomarker discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In HIV infection, sustained microglial activation driven by viral proteins and CCR2-mediated monocyte trafficking, combined with IDO1-induced kynurenine pathway dysregulation and elevated CSF IL-6 and TNF-alpha, produces depressive symptoms in 30–50% of people living with HIV independent of viral load or antiretroviral status”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [9]
In the citing paper
“a 2023 scoping review identified IL-6, TNF-alpha, and neopterin as the most consistent neuroimmune biomarkers linking HIV to depression, with chronically activated microglia proposed as the central mechanistic node [9, 10].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · cited 2×
“For instance, TNF-α regulates the release of chemokines such as MCP-1 and IP-10.(108) The cytokines TNF-α and IL-1β regulate the production of IL-6, all of which in turn induce the release of CRP.”
BackgroundShorey, S., Ng, E. D., & Wong, C. H. J. (2022) · British Journal of Clinical Psychology · doi:10.1111/bjc.12333 · Cited by 1,511 · cited 3×
“Together with widespread stigma and marginalization, these factors contribute to the high risk for depression amongst people with HIV, especially for women with HIV and those in the Global South.4,5 However, as the brain is a key reservoir of HIV infection, it is likely that neurobiological processes also contribute t…”
BackgroundWorldwide burden of HIV in transgender women: a systematic review and meta-analysis.
Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70315-8 · Cited by 1,461
Danese, A., Moffitt, T. E., Harrington, H., Milne, B. J., Polanczyk, G., Pariante, C. M., Poulton, R., & Caspi, A. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.214 · Cited by 1,165 · cited 1×
“Many inflammatory insults, including clinical conditions such as rheumatoid arthritis and psychosocial stressors such as early life adversity, result in an increased risk for depression.(11,12) The connection between neuroinflammation and depression is therefore not”
BackgroundHaapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080 · cited 1×
“ment protein which is constitutively expressed in astrocytes, and thus, serves as a marker of astrocyte activation and CNS pathologies.(72) Ellis et al.”
BackgroundCRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 1×
“Decreased BDNF has been linked with depression in rigorous meta-analyses, though the effect size of this association is relatively small.(89) Neuroimmune biomarkers of depression in HIV BRAIN COMMUNICATIONS 2023: Page 11 of 19 | 11”
Background
Research works printed but not linked: 100
- Bhadra, 2020, Depression and coping strategies among Vietnamese women living with HIV: A qualitative study, Glob Public Health, 15, 1050, 10.1080/17441692.2020.1731566 · DOI
- Ciesla, 2001, Meta-analysis of the relationship between HIV infection and risk for depressive disorders, Am J Psychiatry, 158, 725, 10.1176/appi.ajp.158.5.725 · DOI · Paper page
- Bigna, 2019, Epidemiology of depressive disorders in people living with HIV in Africa: A systematic review and meta-analysis: Burden of depression in HIV in Africa, Gen Hosp Psychiatry, 57, 13, 10.1016/j.genhosppsych.2018.10.005 · DOI
- Hoare, 2021, Global systematic review of common mental health disorders in adults living with HIV, Curr HIV/AIDS Rep, 18, 569, 10.1007/s11904-021-00583-w · DOI
- Del Guerra, 2013, Human immunodeficiency virus-associated depression: Contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways, J Neurovirol, 19, 314, 10.1007/s13365-013-0177-7 · DOI
- Graham, 2020, MRS Suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infection, NeuroImage Clin, 28, 102505, 10.1016/j.nicl.2020.102505 · DOI
- Rakshasa-Loots, 2022, Neuroinflammation in HIV-associated depression: Evidence and future perspectives, Mol Psychiatry, 27, 3619, 10.1038/s41380-022-01619-2 · DOI
- Platchek, 2020, Comparative analysis of multiple immunoassays for cytokine profiling in drug discovery, SLAS Discov, 25, 1197, 10.1177/2472555220954389 · DOI
- Liu, 2021, Cytokines: From clinical significance to quantification, Adv Sci, 8, 2004433, 10.1002/advs.202004433 · DOI · Paper page
- Kim, 2020, Association between depression and rheumatoid arthritis: Two longitudinal follow-up studies using a national sample cohort, Rheumatology, 59, 1889, 10.1093/rheumatology/kez559 · DOI
- Anderson, 2021, Soluble biomarkers of cognition and depression in adults with HIV infection in the combination therapy era, Curr HIV/AIDS Rep, 18, 558, 10.1007/s11904-021-00581-y · DOI
- Oestreich, 2022, Transdiagnostic in vivo magnetic resonance imaging markers of neuroinflammation, Biol Psychiatry Cogn Neurosci Neuroimaging, 7, 638
- Wan, 2014, Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range, BMC Med Res Methodol, 14, 135, 10.1186/1471-2288-14-135 · DOI · Paper page
- Higgins, 2019, Cochrane handbook for systematic reviews of interventions, 10.1002/9781119536604 · DOI · Paper page
- Anderson, 2022, Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV, J Acquir Immune Defic Syndr, 91, 325, 10.1097/QAI.0000000000003063 · DOI
- Cassol, 2015, Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression, J Acquir Immune Defic Syndr, 69, 18, 10.1097/QAI.0000000000000551 · DOI
- Chahine, 2021, Blue Monday: Co-occurring stimulant use and HIV persistence predict dysregulated catecholamine synthesis, J Acquir Immune Defic Syndr, 86, 353, 10.1097/QAI.0000000000002560 · DOI
- Daniels, 2022, Lifetime sexual violence exposure in women compromises systemic innate immune mediators associated with HIV pathogenesis: A cross-sectional analysis, Womens Health, 18, 11
- Derry, 2022, Links between inflammation, mood, and physical function among older adults with HIV, J Gerontol B Psychol Sci Soc Sci, 77, 50, 10.1093/geronb/gbab027 · DOI
- Derry-Vick, 2022, Pain is associated with depressive symptoms, inflammation, and poorer physical function in older adults with HIV, Psychosom Med, 84, 957, 10.1097/PSY.0000000000001119 · DOI
- Drivsholm, 2021, Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV, J Acquir Immune Defic Syndr, 87, e177, 10.1097/QAI.0000000000002664 · DOI
- Ellis, 2021, Social isolation is linked to inflammation in aging people with HIV and uninfected individuals, J Acquir Immune Defic Syndr, 86, 600, 10.1097/QAI.0000000000002596 · DOI
- Ellis, 2020, Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV, Brain Behav Immun Health, 7, 100121, 10.1016/j.bbih.2020.100121 · DOI
- Ghosh, 2018, Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women, PLoS One, 13, e0198412
- Gold, 2014, Longitudinal characterization of depression and mood states beginning in primary HIV infection, AIDS Behav, 18, 1124, 10.1007/s10461-013-0688-5 · DOI
- Hellmuth, 2017, Depression and anxiety are common in acute HIV infection and associate with plasma immune activation, AIDS Behav, 21, 3238, 10.1007/s10461-017-1788-4 · DOI
- Keegan, 2016, Tryptophan metabolism and its relationship with depression and cognitive impairment among HIV-infected individuals, Int J Tryptophan Res, 9, 79, 10.4137/IJTR.S36464 · DOI
- Lu, 2019, Inflammation and risk of depression in HIV: Prospective findings from the multicenter AIDS cohort study, Am J Epidemiol, 188, 1994, 10.1093/aje/kwz190 · DOI
- Martinez, 2014, Reversal of the kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans, J Acquir Immune Defic Syndr, 65, 456, 10.1097/QAI.0000000000000062 · DOI · Paper page
- Memiah, 2021, Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania, BMC Public Health, 21, 1113, 10.1186/s12889-021-11064-5 · DOI
- Mukerji, 2021, Low neuroactive steroids identifies a biological subtype of depression in adults with human immunodeficiency virus on suppressive antiretroviral therapy, J Infect Dis, 223, 1601, 10.1093/infdis/jiaa104 · DOI
- Musinguzi, 2018, Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda, BMC Immunol, 19, 1, 10.1186/s12865-017-0239-3 · DOI
- Norcini Pala, 2016, Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients, Brain Behav Immun, 56, 105, 10.1016/j.bbi.2016.02.013 · DOI
- Poudel-Tandukar, 2014, C-reactive protein and depression in persons with human immunodeficiency virus infection: The positive living with HIV (POLH) study, Brain Behav Immun, 42, 89, 10.1016/j.bbi.2014.06.004 · DOI
- Poudel-Tandukar, 2017, Serum albumin levels and depression in people living with human immunodeficiency virus infection: A cross-sectional study, J Psychosom Res, 101, 38, 10.1016/j.jpsychores.2017.08.005 · DOI
- Rubin, 2020, Remitted depression and cognition in HIV: The role of cortisol and inflammation, Psychoneuroendocrinology, 114, 104609, 10.1016/j.psyneuen.2020.104609 · DOI
- Saloner, 2020, Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease, Brain Behav Immun, 90, 353, 10.1016/j.bbi.2020.09.012 · DOI
- Saloner, 2021, Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV, J Neurovirol, 27, 160, 10.1007/s13365-020-00925-1 · DOI
- Saloner, 2022, Neopterin relates to lifetime depression in older adults with HIV on suppressive antiretroviral therapy, J Acquir Immune Defic Syndr, 89, 454, 10.1097/QAI.0000000000002883 · DOI
- Saylor, 2019, Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in rakai, Uganda, J Neurovirol, 25, 735, 10.1007/s13365-019-00759-6 · DOI
- Stewart, 2020, Associations of total, cognitive/affective, and somatic depressive symptoms and antidepressant use with cardiovascular disease-relevant biomarkers in HIV: Veterans aging cohort study, Psychosom Med, 82, 461, 10.1097/PSY.0000000000000808 · DOI
- Vadaq, 2022, Microbiome-Related indole and serotonin metabolites are linked to inflammation and psychiatric symptoms in people living with HIV, Int J Tryptophan Res, 15, 11786469221126888, 10.1177/11786469221126888 · DOI
- Woods, 2021, Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease, J Neurovirol, 27, 70, 10.1007/s13365-020-00916-2 · DOI
- Zuñiga, 2020, Biomarkers panels can predict fatigue, depression and pain in persons living with HIV: A pilot study, Appl Nurs Res, 52, 151224, 10.1016/j.apnr.2019.151224 · DOI
- Rivera-Rivera, 2014, Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant/antioxidant balance in HIV-1-infected subjects undergoing antiretroviral therapy, J Clin Cell Immunol, 5, 1000276
- Hunt, 2012, HIV And inflammation: Mechanisms and consequences, Curr HIV/AIDS Rep, 9, 139, 10.1007/s11904-012-0118-8 · DOI · Paper page
- Gigase, 2023, The association between inflammatory markers in blood and cerebrospinal fluid: A systematic review and meta-analysis, Mol Psychiatry, 28, 1502, 10.1038/s41380-023-01976-6 · DOI
- Williams, 2021, Associations between antiretroviral drugs on depressive symptomatology in homogenous subgroups of women with HIV, J Neuroimmune Pharmacol, 16, 181, 10.1007/s11481-019-09899-2 · DOI
- Voils, 2011, Combining adjusted and unadjusted findings in mixed research synthesis, J Eval Clin Pract, 17, 429, 10.1111/j.1365-2753.2010.01444.x · DOI · Paper page
- Archer, 2019, Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder, Alcohol, 81, 21, 10.1016/j.alcohol.2019.02.001 · DOI
- Małujło-Balcerska, 2022, Chemokine (C–C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder, Pharmacol Rep, 74, 759, 10.1007/s43440-022-00360-5 · DOI
- Furtado, 2015, Examining the role of neuroinflammation in major depression, Psychiatry Res, 229, 27, 10.1016/j.psychres.2015.06.009 · DOI · Paper page
- Cavaleri, 2022, Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis, Prog Neuropsychopharmacol Biol Psychiatry, 120, 110633, 10.1016/j.pnpbp.2022.110633 · DOI
- Nemeth, 2014, Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats, PloS one, 9, e108399, 10.1371/journal.pone.0108399 · DOI
- Stuart, 2014, Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies, Neurosci Biobehav Rev, 42, 93, 10.1016/j.neubiorev.2014.02.001 · DOI · Paper page
- Lu, 2019, Inflammation and risk of depression in HIV: Prospective findings from the multicenter AIDS cohort study, Am J Epidemiol, 188, 1994, 10.1093/aje/kwz190 · DOI
- Devaraj, 2009, C-reactive protein induces M-CSF release and macrophage proliferation, J Leukoc Biol, 85, 262, 10.1189/jlb.0808458 · DOI · Paper page
- Rhodes, 2011, C-reactive protein in rheumatology: Biology and genetics, Nat Rev Rheumatol, 7, 282, 10.1038/nrrheum.2011.37 · DOI · Paper page
- Karmen-Tuohy, 2020, Outcomes among HIV-positive patients hospitalized with COVID-19, J Acquir Immune Defic Syndr, 85, 6, 10.1097/QAI.0000000000002423 · DOI · Paper page
- Wada, 2022, Long-term trajectories of C-reactive protein among men living with and without HIV infection in the multicenter AIDS cohort study, J Gerontol Ser A, 77, 1382, 10.1093/gerona/glab190 · DOI
- Shive, 2015, Soluble CD14 is a nonspecific marker of monocyte activation, AIDS, 29, 1263, 10.1097/QAD.0000000000000735 · DOI · Paper page
- Ellis, 2022, Astrocyte activation is A potential mechanism underlying depressed mood and apathy in people with HIV, J Neurol Psychol, 9, 05, 10.13188/2332-3469.1000048 · DOI
- Cowen, 2015, What has serotonin to do with depression?, World Psychiatry, 14, 158, 10.1002/wps.20229 · DOI · Paper page
- Argolo, 2022, Activation of the kynurenine pathway and production of inflammatory cytokines by astrocytes and microglia infected with neospora caninum, Int J Tryptophan Res, 15, 11786469211069946, 10.1177/11786469211069946 · DOI
- Routy, 2015, Clinical relevance of kynurenine pathway in HIV/AIDS: An immune checkpoint at the crossroads of metabolism and inflammation, AIDS Rev, 17, 96
- Mehraj, 2015, Tryptophan catabolism in chronic viral infections: Handling uninvited guests, Int J Tryptophan Res, 8, 41, 10.4137/IJTR.S26862 · DOI · Paper page
- Bipath, 2015, The kynurenine pathway activities in a sub-saharan HIV/AIDS population, BMC Infect Dis, 15, 346, 10.1186/s12879-015-1087-5 · DOI
- Savitz, 2022, Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid, Psychol Med, 52, 2500, 10.1017/S0033291720004389 · DOI
- Mikuła, 2018, Significance of heparin-binding protein and D-dimers in the early diagnosis of spontaneous bacterial peritonitis, Mediators Inflamm, 2018:, 1969108, 10.1155/2018/1969108 · doi:10.1155/2018/1969108
- Musselwhite, 2016, Vitamin D, D-dimer, interferon γ, and sCD14 levels are independently associated with immune reconstitution inflammatory syndrome: A prospective, international study, EBioMedicine, 4, 115, 10.1016/j.ebiom.2016.01.016 · DOI
- Grund, 2016, Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy, PloS One, 11, e0155100, 10.1371/journal.pone.0155100 · DOI · Paper page
- von Känel, 2021, Longitudinal association between cognitive depressive symptoms and D-dimer levels in patients following acute myocardial infarction, Clin Cardiol, 44, 1316, 10.1002/clc.23689 · DOI
- Michael, 2020, The role of brain derived neurotrophic factor in HIV-associated neurocognitive disorder: From the bench-top to the bedside, Neuropsychiatr Dis Treat, 16, 355, 10.2147/NDT.S232836 · DOI
- Wenzel, 2019, HIV-associated neurodegeneration: Exploitation of the neuronal cytoskeleton, J Neurovirol, 25, 301, 10.1007/s13365-019-00737-y · DOI
- Morichi, 2012, Expressions of brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid and plasma of children with meningitis and encephalitis/encephalopathy, Int J Neurosci, 123, 17, 10.3109/00207454.2012.721829 · DOI
- Wu, 2020, BDNF Reverses aging-related microglial activation, J Neuroinflammation, 17, 210, 10.1186/s12974-020-01887-1 · DOI · Paper page
- Gibney, 2013, Poly I: C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression, Brain Behav Immun, 28, 170, 10.1016/j.bbi.2012.11.010 · DOI · Paper page
- Bansal, 2022, Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating nrf2/ARE pathway in mouse model of depression: In-vivo and in-silico studies, Neuropharmacology, 215, 109169, 10.1016/j.neuropharm.2022.109169 · DOI
- Best, 2019, New and old TSPO PET radioligands for imaging brain microglial activation in neurodegenerative disease, Curr Neurol Neurosci Rep, 19, 24, 10.1007/s11910-019-0934-y · DOI
- Witcomb, 2018, Levels of depression in transgender people and its predictors: Results of a large matched control study with transgender people accessing clinical services, J Affect Disord, 235, 308, 10.1016/j.jad.2018.02.051 · DOI · Paper page
- UNAIDS, 2022, Fact sheet—Latest global and regional statistics on the status of the AIDS epidemic
- Sia, 2016, What explains gender inequalities in HIV/AIDS prevalence in sub-saharan Africa? Evidence from the demographic and health surveys, BMC Pub Health, 16, 1136, 10.1186/s12889-016-3783-5 · DOI
- Jentsch, 2020, Gender differences in developing biomarker-based major depressive disorder diagnostics, Int J Mol Sci, 21, 3039, 10.3390/ijms21093039 · DOI
- Kim, 2021, Sex difference in peripheral inflammatory biomarkers in drug-naïve patients with major depression in young adulthood, Biomedicines, 9, 708, 10.3390/biomedicines9070708 · DOI
- Raghavan, 2017, Sex differences in select non-communicable HIV-associated comorbidities: Exploring the role of systemic immune activation/inflammation, Curr Hiv/Aids Rep, 14, 220, 10.1007/s11904-017-0366-8 · DOI
- Rakshasa-Loots, 2022, Equity in HIV mental health research: A call to action, Mol Psychiatry, 27, 4824, 10.1038/s41380-022-01748-8 · DOI
- Slaats, 2016, IL-1β/IL-6/CRP and IL-18/ferritin: Distinct inflammatory programs in infections, PLoS Pathog., 12, e1005973, 10.1371/journal.ppat.1005973 · DOI · Paper page
- Ichise, 2020, Soluble CD14 induces pro-inflammatory cytokines in rheumatoid arthritis fibroblast-like synovial cells via toll-like receptor 4, Cells, 9, 1689, 10.3390/cells9071689 · DOI
- Guillemin, 2003, Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes, Glia, 41, 371, 10.1002/glia.10175 · DOI · Paper page
- McLaurin, 2021, HIV-Associated Apathy/Depression and neurocognitive impairments reflect persistent dopamine deficits, Cells, 10, 2158, 10.3390/cells10082158 · DOI
- Rakshasa-Loots A, 2023, Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms, Transl Psychiatry, 13, 190, 10.1038/s41398-023-02489-0 · DOI
- Wang, 2022, Microglia in depression: An overview of microglia in the pathogenesis and treatment of depression, J Neuroinflammation, 19, 132, 10.1186/s12974-022-02492-0 · DOI · Paper page
- Cao, 2021, Early-life inflammation promotes depressive symptoms in adolescence via microglial engulfment of dendritic spines, Neuron, 109, 2573, 10.1016/j.neuron.2021.06.012 · DOI · Paper page
- Dos Reis, 2020, Modeling HIV-1 neuropathogenesis using three-dimensional human brain organoids (hBORGs) with HIV-1 infected microglia, Sci Rep, 10, 15209, 10.1038/s41598-020-72214-0 · DOI · Paper page
- Colombo, 2016, Astrocytes: Key regulators of neuroinflammation, Trends Immunol, 37, 608, 10.1016/j.it.2016.06.006 · DOI · Paper page
- Norden, 2016, Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge, Glia, 64, 300, 10.1002/glia.22930 · DOI · Paper page
- Willis, 2018, Understanding the experience and manifestation of depression in adolescents living with HIV in Harare, Zimbabwe, PLoS One, 13, e0190423, 10.1371/journal.pone.0190423 · DOI · Paper page
- Wagner, 2022, Increased depression during COVID-19 lockdown associated with food insecurity and antiretroviral non-adherence among people living with HIV in Uganda, AIDS Behav, 26, 2182, 10.1007/s10461-021-03371-0 · DOI
- Bosire, 2021, Patients’ experiences of comorbid HIV/AIDS and diabetes care and management in soweto, South Africa, Qual Health Res, 31, 373, 10.1177/1049732320967917 · DOI
- Pérez-Santiago, 2021, Gut microbiota dysbiosis is associated with worse emotional states in HIV infection, J Neurovirol, 27, 228, 10.1007/s13365-020-00933-1 · DOI
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Mudra Rakshasa-Loots, A.
- Venue
- Brain Communications
- Publisher
- Oxford University Press (OUP)
- Published
- 2023
- Volume
- 5
- Issue
- 5
- ISSN
- 2632-1297
- Cited by
- 25
- References
- 25
- Language
- en
- Funders
- Wellcome Trust (218493/Z/19/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression and HIV: a scoping review in search of neuroimmune biomarkers. https://app.cochat.ai/papers/10.1093/braincomms/fcad231
- The paper
- Mudra Rakshasa-Loots, A. (2023). Depression and HIV: a scoping review in search of neuroimmune biomarkers. Brain Communications. https://doi.org/10.1093/braincomms/fcad231
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.